Wealth Enhancement Advisory Services’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$452K Buy
6,890
+118
+2% +$6.71K ﹤0.01% 2780
2026
Q1
$448K Buy
6,772
+467
+7% +$42.6K ﹤0.01% 2404
2025
Q4
$856K Buy
6,305
+55
+0.9% +$7.55K ﹤0.01% 2060
2025
Q3
$755K Buy
+6,250
New +$681K ﹤0.01% 2047

Other funds holding WGS

Wealth Enhancement Advisory Services's WGS Position: Q2 2026 in Review

Wealth Enhancement Advisory Services increased its GeneDx Holdings (WGS) stake by 1.7% in Q2 2026, buying an estimated $6.71K and bringing the position to 6,890 shares worth $452K. The position accounts for ﹤0.01% of the portfolio, ranked #2780.

Wealth Enhancement Advisory Services first reported a position in WGS in Q3 2025 and has held it in 4 quarters since. The position peaked at $856K in Q4 2025. 18 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • Wealth Enhancement Advisory Services held 6,890 shares of GeneDx Holdings worth $452K as of Q2 2026.
  • Wealth Enhancement Advisory Services bought 118 GeneDx Holdings shares in Q2 2026, an estimated $6.71K.
  • GeneDx Holdings made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #2780 holding.
  • Wealth Enhancement Advisory Services first reported a position in GeneDx Holdings in Q3 2025 and has held it in 4 quarters since.
  • Wealth Enhancement Advisory Services's GeneDx Holdings position peaked at $856K in Q4 2025.
  • 18 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.